Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Iwamoto

Showing results (131-140 of 200) with videos related to

Pageof 20
Sort By:
Therapeutics and Clinical Risk Management|August 17, 2011
Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fracturesJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Journal of Bone and Mineral Metabolism|June 10, 2010
Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational studyMasayuki Takakuwa, Jun Iwamoto, Masahisa Konishi, et al.
Therapeutics and Clinical Risk Management|May 14, 2010
Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosisJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Therapeutics and Clinical Risk Management|August 27, 2009
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosisJun Iwamoto, Mitsuyoshi Uzawa, Yoshihiro Sato, et al.
JAMA|March 3, 2005
Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trialYoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2005
Abnormal bone and calcium metabolism in immobilized Parkinson's disease patientsYoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, et al.
Yonsei Medical Journal|February 29, 2008
Comparison of effects of alendronate and raloxifene on lumbar bone mineral density, bone turnover, and lipid metabolism in elderly women with osteoporosisJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Diabetes Research and Clinical Practice|April 29, 2011
RETRACTED: Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetesJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Therapeutics and Clinical Risk Management|January 6, 2011
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fracturesJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Drugs & Aging|January 12, 2012
Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without renal dysfunction: a retrospective studyJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Pageof 20

Showing results (131-140 of 200) with videos related to

Sort By:
Pageof 20
Therapeutics and Clinical Risk Management|August 17, 2011
Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fracturesJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Journal of Bone and Mineral Metabolism|June 10, 2010
Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational studyMasayuki Takakuwa, Jun Iwamoto, Masahisa Konishi, et al.
Therapeutics and Clinical Risk Management|May 14, 2010
Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosisJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Therapeutics and Clinical Risk Management|August 27, 2009
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosisJun Iwamoto, Mitsuyoshi Uzawa, Yoshihiro Sato, et al.
JAMA|March 3, 2005
Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trialYoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2005
Abnormal bone and calcium metabolism in immobilized Parkinson's disease patientsYoshihiro Sato, Yoshiaki Honda, Jun Iwamoto, et al.
Yonsei Medical Journal|February 29, 2008
Comparison of effects of alendronate and raloxifene on lumbar bone mineral density, bone turnover, and lipid metabolism in elderly women with osteoporosisJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Diabetes Research and Clinical Practice|April 29, 2011
RETRACTED: Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetesJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Therapeutics and Clinical Risk Management|January 6, 2011
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fracturesJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Drugs & Aging|January 12, 2012
Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without renal dysfunction: a retrospective studyJun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al.
Pageof 20